BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 18765394)

  • 1. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive improvement in cardiac performance with continuous aortic flow augmentation (aortic flow therapy) in patients hospitalized with severe heart failure: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Zile MR; Colombo PC; Mehra M; Greenberg B; Brown S; Konstam MA
    J Heart Lung Transplant; 2010 Jan; 29(1):86-92. PubMed ID: 20123246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: the MOMENTUM trial.
    Greenberg B; Czerska B; Abraham WT; Neaton JD; Delgado RM; Mather P; Bourge R; Parker IC; Konstam MA;
    J Card Fail; 2007 Nov; 13(9):715-21. PubMed ID: 17996819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute left ventricular unloading in dogs with chronic heart failure: continuous aortic flow augmentation versus intra-aortic balloon pumping.
    Sabbah HN; Wang M; Gupta RC; Rastogi S; Ilsar I; Viole T; Brewer R
    J Card Fail; 2009 Aug; 15(6):523-8. PubMed ID: 19643364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
    Schofield RS; Pierce GL; Nichols WW; Klodell CT; Aranda JM; Pauly DF; Hill JA; Braith RW
    Am J Hypertens; 2007 Jun; 20(6):622-8. PubMed ID: 17531918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.
    Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R;
    Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure.
    Konstam MA; Czerska B; Böhm M; Oren RM; Sadowski J; Khanal S; Abraham WT; Wasler A; Dahm JB; Gavazzi A; Gradinac S; Legrand V; Mohacsi P; Poelzl G; Radovancevic B; Van Bakel AB; Zile MR; Cabuay B; Bartus K; Jansen P
    Circulation; 2005 Nov; 112(20):3107-14. PubMed ID: 16275867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.
    Mann DL; Acker MA; Jessup M; Sabbah HN; Starling RC; Kubo SH;
    Ann Thorac Surg; 2007 Oct; 84(4):1226-35. PubMed ID: 17888974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience with the AbioCor implantable replacement heart system.
    Dowling RD; Gray LA; Etoch SW; Laks H; Marelli D; Samuels L; Entwistle J; Couper G; Vlahakes GJ; Frazier OH
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):131-41. PubMed ID: 14752423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump.
    Meyns B; Klotz S; Simon A; Droogne W; Rega F; Griffith B; Dowling R; Zucker MJ; Burkhoff D
    J Am Coll Cardiol; 2009 Jun; 54(1):79-86. PubMed ID: 19555845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device.
    Travis AR; Giridharan GA; Pantalos GM; Dowling RD; Prabhu SD; Slaughter MS; Sobieski M; Undar A; Farrar DJ; Koenig SC
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):517-24. PubMed ID: 17258591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a pulsatile pediatric ventricular assist device in an acute right heart failure model.
    Shum-Tim D; Duncan BW; Hraska V; Friehs I; Shin'oka T; Jonas RA
    Ann Thorac Surg; 1997 Nov; 64(5):1374-80. PubMed ID: 9386707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
    Khan T; Levin HR; Oz MC; Katz SD
    J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.